medroxyprogesterone acetate has been researched along with Female Genital Neoplasms in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (42.86) | 18.7374 |
1990's | 5 (35.71) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, GL; Barad, DH; Beresford, SA; Judd, HL; Kaunitz, AM; Liu, J; Lopez, AM; McNeeley, SG; Pettinger, M | 1 |
Gitsch, E; Salzer, H | 1 |
Gantt, PA; Hunt, JB; McDonough, PG | 1 |
Kaunitz, AM; Rosenfield, A | 1 |
Fraser, I; Hickey, M | 1 |
Fukushima, A; Matsuta, M; Nishiya, I; Satoh, K; Yoshizaki, A | 1 |
Kaunitz, AM | 1 |
Ichikawa, Y; Yoshikawa, H | 1 |
Curtin, JP; Hines, BJ; Mittal, K; Muggia, FM; Porges, RF | 1 |
Bonte, J; Vanderstappen, D | 1 |
Fujimoto, J; Fujita, H; Hosoda, S; Okada, H | 1 |
Hashii, K; Kamitani, N; Kanto, T; Mori, T; Natsuyama, S; Tateyama, I; Tominaga, T | 1 |
Kauppila, AJ; Rönnberg, L; Telimaa, S | 1 |
Hayes, MF; Hull, ME; Magyar, DM; Moghissi, KS | 1 |
6 review(s) available for medroxyprogesterone acetate and Female Genital Neoplasms
Article | Year |
---|---|
Injectable contraception with depot medroxyprogesterone acetate. Current status.
Topics: Adult; Bone Density; Contraceptives, Oral; Delayed-Action Preparations; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Reproduction; Risk Factors | 1993 |
The contraceptive use of depot medroxyprogesterone acetate.
Topics: Animals; Bone and Bones; Breast Neoplasms; Clinical Trials as Topic; Contraceptive Agents, Female; Contraindications; Dose-Response Relationship, Drug; Female; Fertility; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Menstrual Cycle; United States; United States Food and Drug Administration | 1995 |
[Recent problems on the endocrine and chemotherapy].
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Cell Cycle; Cisplatin; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Paclitaxel | 1995 |
Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
Topics: Breast Neoplasms; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Neoplasms; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Risk Factors | 1996 |
[Minimally invasive treatment of gynecologic cancers].
Topics: Antineoplastic Agents, Hormonal; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Minimally Invasive Surgical Procedures; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms | 2001 |
New trends in the use of medroxyprogesterone acetate as a chemotherapeutic agent in gynecologic malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen | 1992 |
2 trial(s) available for medroxyprogesterone acetate and Female Genital Neoplasms
Article | Year |
---|---|
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
Topics: Aged; Biopsy; Double-Blind Method; Endometrial Neoplasms; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Postmenopause; Proportional Hazards Models; Uterine Cervical Neoplasms; Vaginal Smears | 2003 |
Steroidal drugs in endometriosis.
Topics: Antineoplastic Agents; Danazol; Double-Blind Method; Endometriosis; Female; Genital Neoplasms, Female; Gestrinone; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norpregnatrienes; Pregnadienes; Pregnancy; Randomized Controlled Trials as Topic | 1989 |
6 other study(ies) available for medroxyprogesterone acetate and Female Genital Neoplasms
Article | Year |
---|---|
[The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
Topics: Breast Neoplasms; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Progesterone; Receptors, Androgen; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1983 |
Progestin reversal of ureteral endometriosis.
Topics: Adult; Delayed-Action Preparations; Endometriosis; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ureteral Obstruction | 1981 |
Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report.
Topics: Adenosarcoma; Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometriosis; Female; Genital Neoplasms, Female; Humans; Medroxyprogesterone Acetate; Mixed Tumor, Mullerian | 2002 |
Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors.
Topics: Adenocarcinoma; Angiogenesis Inducing Agents; Carcinoma, Squamous Cell; Cell Division; Cystadenocarcinoma; Female; Fibroblast Growth Factors; Genital Neoplasms, Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neovascularization, Pathologic; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Experimental local administration of CDDP to in vitro models of gynecological malignant tumors transplanted into nude mice (compared with medroxyprogesterone acetate orally administered).
Topics: Administration, Oral; Administration, Topical; Animals; Antineoplastic Agents; Cisplatin; Female; Genital Neoplasms, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 1989 |
Comparison of different treatment modalities of endometriosis in infertile women.
Topics: Danazol; Endometriosis; Female; Genital Neoplasms, Female; Humans; Infertility, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy | 1987 |